Insulin Updates: March 2023 - Life Sciences, Biotechnology & Nanotechnology
Last Tuesday, Novo Nordisk, made an announcement that it too would be cutting the U.S. list price of its insulin products, including NOVOLOG insulin...
Stay updated with breaking news from Insulin Value Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Last Tuesday, Novo Nordisk, made an announcement that it too would be cutting the U.S. list price of its insulin products, including NOVOLOG insulin...
On March 1, Eli Lilly was the first to announce U.S. list price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps...
The product is not expected on store shelves until at least next year.
Starting next month, some Medicare beneficiaries will pay less out of pocket for 27 prescription drugs whose prices rose faster than inflation late last year.
Danish pharmaceutical company Novo Nordisk has announced it is lowering the U.S. list prices of several insulin products by up to 75% for people living with Type 1 and type 2 diabetes. It becomes the second drugmaker to do so, following Eli Lilly's announcement earlier this month that it was capping out-of-pocket costs to $35 a month for insulin. Novo Nordisk products include